Q: What were some of your most satisfying successes of the past year, and why? I've had the privilege of representing clients in a number of the most prominent transactions globally over the past year, including Pfizer in its $43 billion acquisition of Seagen, the Special Transaction Committee of the Board of DISH Network in its $22 billion combination with EchoStar, Hess in its $60 billion acquisition by Chevron and Diamondback Energy in its $26 billion merger with Endeavor Energy Resources.